Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Sung-En Wang, Dr.P.H., M.D.

Co-Author

This page shows the publications co-authored by Philip Wang and Jerome Avorn.
Connection Strength

3.692
  1. Suboptimal antidepressant use in the elderly. J Clin Psychopharmacol. 2005 Apr; 25(2):118-26.
    View in: PubMed
    Score: 0.315
  2. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model. J Ment Health Policy Econ. 2004 Jun; 7(2):77-85.
    View in: PubMed
    Score: 0.297
  3. Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. Ann Epidemiol. 2004 Apr; 14(4):296-303.
    View in: PubMed
    Score: 0.294
  4. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9.
    View in: PubMed
    Score: 0.289
  5. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry. 2002 Dec; 59(12):1147-54.
    View in: PubMed
    Score: 0.268
  6. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002 Jul; 17(7):504-11.
    View in: PubMed
    Score: 0.260
  7. Clozapine use and risk of diabetes mellitus. J Clin Psychopharmacol. 2002 Jun; 22(3):236-43.
    View in: PubMed
    Score: 0.259
  8. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients. J Am Geriatr Soc. 2002 Jan; 50(1):117-24.
    View in: PubMed
    Score: 0.251
  9. Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants. J Ment Health Policy Econ. 2010 Mar; 13(1):37-44.
    View in: PubMed
    Score: 0.111
  10. The impact of cost sharing on antidepressant use among older adults in British Columbia. Psychiatr Serv. 2008 Apr; 59(4):377-83.
    View in: PubMed
    Score: 0.097
  11. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol. 2007 Dec; 27(6):707-10.
    View in: PubMed
    Score: 0.095
  12. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial. JAMA. 2007 Sep 26; 298(12):1401-11.
    View in: PubMed
    Score: 0.093
  13. The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry. 2006 Dec; 63(12):1345-53.
    View in: PubMed
    Score: 0.088
  14. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006 Aug; 59(8):819-28.
    View in: PubMed
    Score: 0.085
  15. Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006 May-Jun; 26(3):247-54.
    View in: PubMed
    Score: 0.085
  16. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
    View in: PubMed
    Score: 0.082
  17. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 01; 353(22):2335-41.
    View in: PubMed
    Score: 0.082
  18. Lipid levels and bone mineral density. Am J Med. 2005 Dec; 118(12):1414.
    View in: PubMed
    Score: 0.082
  19. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model. J Clin Psychopharmacol. 2005 Oct; 25(5):427-34.
    View in: PubMed
    Score: 0.081
  20. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9.
    View in: PubMed
    Score: 0.080
  21. Statin lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Saf. 2005 Apr; 14(4):219-26.
    View in: PubMed
    Score: 0.079
  22. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med. 2004 Sep 27; 164(17):1858-64.
    View in: PubMed
    Score: 0.076
  23. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003 Feb 15; 21(4):602-6.
    View in: PubMed
    Score: 0.068
  24. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Control Clin Trials. 2002 Dec; 23(6):757-73.
    View in: PubMed
    Score: 0.067
  25. Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum. 2006 Feb 15; 55(1):35-41.
    View in: PubMed
    Score: 0.021
  26. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004 Aug 9-23; 164(15):1641-9.
    View in: PubMed
    Score: 0.019
  27. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med. 2004 May; 19(5 Pt 1):444-50.
    View in: PubMed
    Score: 0.018
  28. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum. 2003 Aug; 48(8):2207-13.
    View in: PubMed
    Score: 0.018
  29. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 Aug; 38(4):1103-20.
    View in: PubMed
    Score: 0.018
  30. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 01; 94(9):652-61.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.